N. Kurucu Et Al. , "Irinotecan and Temozolamide Treatment -Alone or Combined with Vincristin and/or Bevacizumab- for Relapsed/Refractory Childhood Cancer," PEDIATRIC BLOOD & CANCER , vol.66, 2019
Kurucu, N. Et Al. 2019. Irinotecan and Temozolamide Treatment -Alone or Combined with Vincristin and/or Bevacizumab- for Relapsed/Refractory Childhood Cancer. PEDIATRIC BLOOD & CANCER , vol.66 .
Kurucu, N., Akyuz, C., Cemaloglu, M., Varan, A., AYDIN, G. B., Yalcin, B., ... Kutluk, T.(2019). Irinotecan and Temozolamide Treatment -Alone or Combined with Vincristin and/or Bevacizumab- for Relapsed/Refractory Childhood Cancer. PEDIATRIC BLOOD & CANCER , vol.66.
Kurucu, N. Et Al. "Irinotecan and Temozolamide Treatment -Alone or Combined with Vincristin and/or Bevacizumab- for Relapsed/Refractory Childhood Cancer," PEDIATRIC BLOOD & CANCER , vol.66, 2019
Kurucu, N. Et Al. "Irinotecan and Temozolamide Treatment -Alone or Combined with Vincristin and/or Bevacizumab- for Relapsed/Refractory Childhood Cancer." PEDIATRIC BLOOD & CANCER , vol.66, 2019
Kurucu, N. Et Al. (2019) . "Irinotecan and Temozolamide Treatment -Alone or Combined with Vincristin and/or Bevacizumab- for Relapsed/Refractory Childhood Cancer." PEDIATRIC BLOOD & CANCER , vol.66.
@article{article, author={N. Kurucu Et Al. }, title={Irinotecan and Temozolamide Treatment -Alone or Combined with Vincristin and/or Bevacizumab- for Relapsed/Refractory Childhood Cancer}, journal={PEDIATRIC BLOOD & CANCER}, year=2019}